MCH ANALYSIS RESEARCHMain site ↗
Industrials

Construction Machinery & Heavy Transportation Equipment

8 companies under coverage.

Coverage

Construction Machinery & Heavy Transportation Equipment


Equity Research

Cummins Inc (CMI)

BUY. 12-month probability-weighted target $661 (+26% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

CMIEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +11.0%
Equity Research

Terex Corporation (TEX)

BUY. 12-month probability-weighted target $64 (+27% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

TEXEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +4.5%
Equity Research

Oshkosh Corporation (OSK)

HOLD. 12-month probability-weighted target $138 (+10% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

OSKEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price +1.7%
Equity Research

PACCAR Inc (PCAR)

HOLD. 12-month probability-weighted target $118 (+9% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

PCAREquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -1.4%
Equity Research

Caterpillar Inc (CAT)

HOLD. 12-month probability-weighted target $993 (+24% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

CATEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -3.6%
Equity Research

Allison Transmission Holdings Inc (ALSN)

HOLD. 12-month probability-weighted target $118 (+7% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALSNEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -9.5%
Equity Research

Westinghouse Air Brake Technologies Corp (WAB)

SELL. 12-month probability-weighted target $252 (-12% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

WABEquity ResearchMonte Carlo
12 October 2026Rating: SELL · Fair value vs price -23.1%
Equity Research

GATX Corporation (GATX)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

GATXEquity ResearchMonte Carlo
1 October 2026Rating: N/A
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies